MDR 2517506-2017-00861, MDR 2517506-2017-00862, MDR 2517506-2017-00863, MDR 2517506-2017-00864, MDR 2517506-2017-00865, MDR 2517506-2017-00867, MDR 2517506-2017-00868, MDR 2517506-2017-00869, MDR 2517506- 2017-00870, MDR 2517506-2017-00871, MDR 2517506-2017-00872, MDR 2517506-2017-00873, MDR 2517506-2017-00874, MDR 2517506-2017-00875 WERE ALSO FILED FOR THE SAME CUSTOMER INQUIRY. THE CUSTOMER CONTACTED SIEMENS CUSTOMER CARE CENTER FOR THE DISCORDANT ELEVATED DIGOXIN RESULT ON THE DIMENSION VISTA INSTRUMENT. QUALITY CONTROL WAS WITHIN SPECIFICATION DURING TESTING. SIEMENS IS INVESTIGATING THE INCIDENT.
D
Patient 1
A DISCORDANT FALSELY ELEVATED DIGOXIN (DIGXN) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON THE DIMENSION VISTA 1500 INSTRUMENT. THE RESULT WAS REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULT. THERE IS NO KNOWN REPORT OF PATIENT ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT FALSELY ELEVATED DIGXN RESULT.